MYRIAD GENETICS INC Common Stock Shares Outstanding

Quick Answer

MYRIAD GENETICS INC reported Common Stock Shares Outstanding of 93.50 million shares for the year ending 2025.

  • MYRIAD GENETICS INC showed an increase of +2.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2012 to 2025), MYRIAD GENETICS INC's Common Stock Shares Outstanding has grown by 13.2%.
  • Historical annual values: Fiscal year 2025: 93.50 million shares | Fiscal year 2024: 91.30 million shares | Fiscal year 2023: 89.90 million shares | Fiscal year 2022: 81.20 million shares | Fiscal year 2021: 80.00 million shares | Fiscal year 2020: 75.40 million shares | Fiscal year 2020: 74.70 million shares | Fiscal year 2019: 73.50 million shares | Fiscal year 2018: 70.60 million shares | Fiscal year 2017: 68.40 million shares | Fiscal year 2016: 69.10 million shares | Fiscal year 2015: 68.90 million shares | Fiscal year 2014: 73.50 million shares | Fiscal year 2013: 80.60 million shares | Fiscal year 2012: 82.57 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: